Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Psychiatric services (Washington, D.C.)

ISSN 1557-9700

4 papers in the library · 3 citations · publishing 2025-2026

Papers

Racial-Ethnic Disparities in Ketamine and Esketamine Therapy for Major Depressive Disorder.

Psychiatric services (Washington, D.C.) June 25, 2025 Michael Liu, Rachel Branning, Austin Lee et al. 2 citations

Non-Hispanic Black, Hispanic, and Asian patients with moderate-to-severe recurrent major depressive disorder received ketamine at lower rates than non-Hispanic White patients. Esketamine was used less often among Black patients, more often among Hispanic patients, and at similar rates among Asian patients compared with White patients. Black and White patients who received either treatment had more co-occurring medical and psychiatric conditions than those who did not. The findings indicate significant racial-ethnic disparities in access to these advanced therapies, especially for Black patients.

Toward Greater Diversity in Psychedelic Science.

Psychiatric services (Washington, D.C.) February 5, 2026 Marcus Hughes 1 citation

Racial-ethnic diversity is lacking in psychedelic science. Efforts to increase representation among clinical trial participants have been made but remain insufficient. This column describes the disparity, outlines potential benefits of eliminating it, and provides recommendations for achieving equity and justice in psychedelic treatment research for mental disorders.

When Off-Label Ketamine Meets Direct-to-Consumer Telehealth: Liability Risks and Ethical Responsibilities.

Psychiatric services (Washington, D.C.) July 1, 2026 Joshua Mitchell, Benjamin Bregman, Renuka Surujnarain et al.

Telehealth platforms expanded access to mental health care during the COVID-19 pandemic, including online prescribing of ketamine for off-label psychiatric use. A wrongful death lawsuit against a telehealth ketamine provider illustrates how combining off-label prescribing with on-demand delivery can weaken clinical safeguards. With limited oversight of many telehealth platforms and the drugs they prescribe, responsibility for patient safety falls heavily on clinicians. To sustain responsible care, structures must support robust clinical relationships, monitoring, and accountability.

Mindfulness-Based Interventions in Schools: Assessing the Evidence Base.

Psychiatric services (Washington, D.C.) January 1, 2025 Tina Marshall, Alden Farrar, Melissa Wilson et al.

A systematic review of school-based mindfulness interventions rated the level of evidence for 24 programs across 41 studies published between 2008 and 2022. Three interventions—Learning to BREATHE, Mindfulness in School Project, and mindfulness-based stress reduction (MBSR)—received a high level of evidence rating. Three others—Gaia Program, MindUP, and a blended MBSR and mindfulness-based cognitive therapy—received a moderate rating. Interventions with high evidence were conducted with middle or high school students; those with moderate evidence also included elementary students, indicating effectiveness across age groups. Few studies examined outcomes for underserved populations.